—

Sanofi

Q4 2025 13F Holdings

  • Location
    paris, I0
  • Num holdings

    8

  • Value ($000)

    $310,415

  • Date Filed
    02/11/2026
  • Form type
    13F-HR
  • CIK
    0001121404
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
---

MeiraGTx Holdings plc

COM
G59665102
$96.97M
31 %

12,197,737

I
INBX

Inhibrx Biosciences, Inc.

COM
45720N103
$91.48M
30 %

1,157,926

N
NVV1

Novavax

COM NEW
670002401
$46.24M
15 %

6,880,481

A
ANAB

AnaptysBio

COM
032724106
$39.85M
13 %

821,917

I
IMRX

Immuneering Corp

CLASS A COM
45254E107
$17.82M
6 %

2,708,559

---

MapLight Therapeutics Inc.

COM
56565P103
$16.02M
5 %

912,041

E
ELDN

Eledon

COM
28617K101
$1.23M
0 %

814,980

Q
QTTB

Q32 Bio Inc.

COM
746964105
$810.36K
0 %

244,083

Rows Per Page
10
  • 5
  • 10
  • 20
  • 30
  • 50
  • 100
1 - 8 of 8